Streetbeat News

Products Services

SSYS

Stratasys has announced the launch of a new direct-to-garment solution for the J850 TechStyle printer, aiming to enhance its offerings in the 3D printing sector.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 12:20 pm

VHAI

Vocodia Holdings Corp (CBOE: VHAI) provided a corporate update highlighting its growth since going public, including strategic partnerships, technological advancements in AI, and financial milestones. The company has launched AI service platforms in global automobile dealerships and a major utility provider, aiming to enhance operational efficiency and customer interaction. With a successful IPO raising $5.95 million and insider investments of $400,000, Vocodia is focusing on expanding its conversational AI technology to redefine customer service standards.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 12:19 pm

EZGO

EZGO Technologies Ltd. (NASDAQ:EZGO) has entered into a five-year strategic cooperation framework agreement with Woteam New Energy to jointly explore the Southeast Asian market by developing automotives and electric products. The partnership aims to integrate EZGO's electric bicycle expertise with Woteam's advanced battery technology to establish production plants across Southeast Asia, enhancing their strategic positioning in intelligent industries. This collaboration is expected to significantly expand EZGO's global market presence, aiming for annual sales of 500,000 electric two-wheeled vehicles and 400,000 sets of lithium batteries, targeting aggregate revenues of $500 million.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 12:07 pm

GSK

GSK plc (NYSE:GSK) announced positive long-term efficacy data for its Shingrix vaccine from the ZOSTER-049 trial, showing sustained efficacy against shingles in adults over 50 for over a decade. The trial included over 7,000 participants, demonstrating vaccine efficacy rates of 79.7% in adults aged 50+ and 73.1% in those 70+ from six to 11 years post-vaccination. Additionally, GSK reported results from the EAGLE-1 Phase 3 trial of gepotidacin, an oral antibiotic for gonorrhea, showing non-inferiority to the standard combination therapy. GSK shares are down 1.15% in premarket trading.

Portfolio Pulse from Vandana Singh

April 17, 2024 | 12:06 pm

HUGE

FSD Pharma has begun investigations into ingredients and dietary supplements aimed at promoting weight loss and liver health. This move could signal a strategic pivot or expansion in the company's product offerings, potentially tapping into the lucrative health and wellness market.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 12:05 pm

ZPTA

Zapata AI (NASDAQ:ZPTA) announced a $1M commercial expansion with Andretti Global, making it Andretti's official AI Partner. This expansion, effective March 28, 2024, aims to enhance Andretti's engineering, operations, and race strategy across multiple racing series through generative AI and technical expertise. The partnership, which began in February 2022, has already seen the development of advanced ML models for race day performance improvements. The new engagement includes building an AI-ready database for Andretti's racing configurations and is expected to contribute to Zapata AI's sequential quarter-over-quarter bookings growth.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 12:03 pm

BNGO

Bionano Genomics has entered into an OEM partnership with Diagens to commercialize a clinical cytogenetic analysis that combines Optical Genome Mapping (OGM) with Artificial Intelligence (AI). This collaboration aims to enhance the capabilities and applications of cytogenetic testing, potentially leading to more accurate and efficient diagnoses.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 12:03 pm

SYRA

Syra Health has announced the continuation of its partnership with Maricopa County, Arizona, for a third public health training session. This session will focus on cultural humility, emphasizing the importance of understanding and respecting diverse cultural backgrounds in healthcare settings.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 11:55 am

CMND

Clearmind Medicine has entered into an exclusive licensing agreement with Yissum Research Development Company of the Hebrew University of Jerusalem. This agreement is for the development of Generation 3.0 psychedelic compounds aimed at treating mental disorders.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 11:50 am

EPM

PED

PEDEVCO, in partnership with Evolution Petroleum Corporation, has successfully drilled and completed three horizontal San Andres wells in the Chaveroo Field, Permian Basin. These wells, drilled in Q4 2023 and completed by early 2024, have commenced production with promising early results, peaking at 300 to 375 BOEPD per well. The wells are currently exceeding expectations with an average production of over 750 BOEPD in the last 30 days, indicating a positive outlook for future development phases.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 11:39 am